John Murphy, Chief Policy Officer, BIO, Discusses CMS Restriction of Coverage of Alzheimer’s Drug
John Murphy, Chief Policy Officer, BIO, comments on the decision by CMS to restrict coverage of Alzheimer’s drug to patients in …
source
John Murphy, Chief Policy Officer, BIO, comments on the decision by CMS to restrict coverage of Alzheimer’s drug to patients in …
source